SCHEMBL3835337

SCHEMBL3835337

CC(C)(C)[Si](C)(C)OCCO[C@H]1CC[C@@H](OCc2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.44
OPRL1 P41146 2/20 0.44
CARM1 Q86X55 3/20 0.42
PRMT6 Q96LA8 3/20 0.42
SIGMAR1 Q99720 2/20 0.42
PRMT8 Q9NR22 2/20 0.42
TMEM97 Q5BJF2 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
DPP4 P27487 1/20 0.41
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSK P43235 1/20 0.38
BCHE P06276 2/20 0.38
EPHX2 P34913 1/20 0.36
PRMT3 O60678 1/20 0.34
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3835338 1.00 OPRM1 (0.44) OPRM1OPRL1CARM1PRMT6SIGMAR1
SCHEMBL13112943 0.85 OPRM1 (0.48) OPRM1OPRL1CARM1PRMT6SIGMAR1
SCHEMBL3827609 0.82 OPRM1 (0.54) OPRM1OPRL1CARM1PRMT6SIGMAR1
SCHEMBL6108529 0.82 OPRM1 (0.54) OPRM1OPRL1CARM1PRMT6SIGMAR1
SCHEMBL17888528 0.79 ACACB (0.44) HRH3
SCHEMBL22034436 0.79 BCHE (0.48) BCHE
SCHEMBL22034476 0.79 BCHE (0.48) BCHE
SCHEMBL25366193 0.79 CARM1 (0.50) CARM1PRMT6SIGMAR1PRMT8TMEM97
SCHEMBL724384 0.78 NAAA (0.41) OPRM1OPRL1CARM1PRMT6SIGMAR1
SCHEMBL6469380 0.76 OPRM1 (0.59) OPRM1OPRL1CARM1PRMT6SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730148-A4 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LAB (US) 2009-08-19 EP disclosed
EP-1730148-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS Abbott Laboratories (US) 2006-12-13 EP disclosed
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABBOTT LABORATORIES 2006-02-02 US disclosed
WO-2005074603-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABL1, MAP3K19, MAP3K20 OPRM1 3876/4885OPRL1 3254/4885CARM1 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.